PRICE T ROWE ASSOCIATES INC /MD/ - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 1 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$478
+19.5%
159,290
-1.9%
0.00%
Q2 2023$400
-1.0%
162,436
-9.0%
0.00%
Q1 2023$404
-38.2%
178,440
-4.8%
0.00%
Q4 2022$654
-100.0%
187,459
-4.6%
0.00%
-100.0%
Q3 2022$7,278,000
+127.1%
196,556
+16.5%
0.00%
Q2 2022$3,205,000
-24.6%
168,757
+7.1%
0.00%
Q1 2022$4,253,000
+1915.6%
157,565
+1855.6%
0.00%
Q3 2021$211,000
-95.8%
8,057
-93.8%
0.00%
-100.0%
Q4 2019$5,049,000129,4610.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 111,550$274,4130.39%
Deep Track Capital, LP 2,837,818$6,981,0320.32%
apricus wealth, LLC 77,329$219,6140.19%
PARSONS CAPITAL MANAGEMENT INC/RI 873,312$2,148,3480.16%
Palo Alto Investors LP 732,400$1,801,7040.15%
RTW INVESTMENTS, LP 2,131,835$5,244,3140.10%
AdvisorShares Investments LLC 112,898$277,7290.08%
GSA CAPITAL PARTNERS LLP 271,524$6680.07%
Spotlight Asset Group, Inc. 20,000$49,2000.04%
Savior LLC 3,500$8,6100.04%
View complete list of RELMADA THERAPEUTICS INC shareholders